Top Markets
Coin of the day
Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF
주식 순위 #41805
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$9.87K
변동 (1일)
0.00%
변동 (1년)
-99.79%
국가
CA
거래 Valeo Pharma Inc. (VPHIF)

카테고리

Valeo Pharma Inc. (VPHIF)의 주가 이력
최고 종가: $0.00 (2026-08-01 기준)

최저 종가: $0.85 (2020-09-01 기준)
Valeo Pharma Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 -99.79%
2024 -64.24%
2023 -71.62%
2022 -18.52%
2021 -36.53%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$171.67 -
DE
$166.06 27.73%
DE
$36.31 22.75%
JP
$228.90 41.12%
CH
$21.40 14.12%
IN